Molecules 2014, 19
7616
3.4. Characterization Data
1-(4-Chlorophenacyl)-3-hydroxy-4-hydroxyiminomethyl-5-hydroxymethyl-2-methylpyridinium bromide
(2). Yellow solid; Rf value: 0.18 (chloroform‒methanol, 6:1.5, v/v); mp after crystallization from
methanol 230–233 °C; FT-IR (KBr) νmax: 3385, 3073–2858, 1688, 1637–1589, 1261, 1051–1003 cm−1;
1H-NMR: δ 12.78 (1H, bs, NOH), 8.67 (1H, bs, OH), 8.59 (1H, s, H-6), 8.14–8.11 (2H, d,
J = 8.62 Hz, H-2', H-6'), 7.77–7.74 (2H, d, J = 8.58 Hz, H-3', H-5'), 6.89 (2H, s, CH2CO), 5.84 (1H,
bs, CH2OH), 4.81 (2H, s, CH2OH), 2.51 (3H, s, CH3); 13C-NMR: δ 189.82 (C, C=O), 152.55 (C, C-3),
145.46 (C, C-2), 139.65 (C, C-6), 137.28 (C, C-4), 135.10 (C, C-4'), 132.25 (C, C-1'), 130.43 (C-2',
C-6'), 129.76 (C-3', C-5'), 128.98 (C, C-5), 64.48 (CH2CO), 58.47 (CH2OH), 13.32 (CH3); MS (m/z):
415.0 [M]+ (54.16), 335.2 (43.05, Br), 333.0 (100), 302.8 (39.58), 164.1 (36.11); Anal. Calcd. for
C16H16N2O4BrCl: C 46.23, H 3.88, N 6.74; Found: C 46.34, H 3.86, N 6.72%.
1-(4'-Bromophenacyl)-3-hydroxy-4-hydroxyiminomethyl-5-hydroxymethyl-2-methylpyridinium bromide
(3) Yellow solid; Rf value: 0.27 (chloroform‒methanol, 6:1.5, v/v); mp after crystallization from
ethyl acetate 195–198 °C; FT-IR (KBr) νmax: 3385, 3073-2849, 1686, 1636–1456, 1261, 1049–980 cm−1;
1H-NMR: δ 12.99 (1H, bs, NOH), 8.66 (1H, bs, OH), 8.63 (1H, s, H-6), 8.04–8.01 (2H, d, J = 8,61 Hz,
H-2', H-6'), 7.92–7.89 (2H, d, J = 8.55 Hz, H-3', H-5'), 6.61 (2H, s, CH2CO), 5.88 (2H, s, CH2OH),
13
4.81 (1H, s, CH2OH), 2.3 (3H, s, CH3); C-NMR: δ 190.02 (C, C=O), 152.47 (C, C-3), 145.44 (C,
C-2), 137.28 (C, C-6), 135.11 (C, C-4), 132.56 (C, C-4'), 132.06 (C, C-1'), 130.43 (C-2', C-6'), 128.93
(C-3', C-5'), 128.16 (C, C-5), 64.37 (CH2CO), 58.46 (CH2OH), 13.28 (CH3); MS (m/z): 460.8 [M]+
(17.48), 379.1 (100), 361.1 (39.16), 349.1 (39,86), 199.0 (34.96), 160.7 (39.16); Anal. Calcd. for
C16H16N2O4Br2 : C 41.77; H 3.50; N 6.09; Found: C 41.96, H 3.61, N 5.97%.
3-Hydroxy-4-hydroxyiminomethyl-5-hydroxymethyl-2-methyl-1-phenacylpyridinium bromide (4). Yellow
solid; Rf value: 0.26 (chloroform‒methanol, 6:1.5, v/v); mp after crystallization from methanol
250–251 °C; FT-IR (KBr) νmax: 3275, 3107–2727, 1701, 1636–1449, 1229, 1084–980 cm−1; 1H-NMR:
δ 12.47 (1H, bs, NOH), 11.52 (1H, bs, OH), 8.62 (1H, s, H-6), 7.72–7.70 (2H, d, J = 7.98 Hz, H-2',
H-6'), 7.39–7.36 (2H, d, J = 8.16 Hz, H-3', H-5'), 6.00 (2H, s, CH2CO), 4.67 (2H, s, CH2OH), 2.51
13
(1H, s, CH2OH), 2.50 (3H, s, CH3). C-NMR: δ 190.70 (C, C=O), 152.50 (C, C-3), 137.21 (C, C-2),
135.11 (C, C-6), 135.10 (C, C-4), 130.44 (C, C-4'), 128.30 (C-2', C-6'), 128.26 (C, C-1'), 128.10, (C-3',
C-5'), 127.82 (C, C-5), 59.67 (CH2CO), 58.44, (CH2OH), 13.25 (CH3); MS (m/z): 381.0 [M]+ (83),
299.3 (100), 281.4 (52.45), 269.2 (37.06), 161.0 (47.55), 106.0 (31.46); Anal. Calcd. for C16H17N2O4Br:
C 50.41, H 4.49, N 7.35, Br 20.96; Found: C 50.58, H 4.33, N 7.48, Br 20.93%.
3-Hydroxy-4-hydroxyiminomethyl-5-hydroxymethyl-2-methyl-1-(4-methylphenacyl)pyridinium bromide
(5). Yellow–light brown solid; Rf value: 0.22 (chloroform‒methanol, 6:1.5, v/v); mp after
crystallization from methanol 240–241.5 °C; FT-IR (KBr) νmax: 3385, 3064–2853, 1684, 1636–1541,
1
1234, 1088–980 cm−1; H-NMR: δ 12.87 (1H, bs, NOH), 8.67 (1H, bs, OH), 8.62 (1H, s, H-6),
8.03–8.00 (2H, d, J = 8.22 Hz; H-3', H-5'), 7.48–7.46 (2H, d, J = 8.07 Hz, H-2', H-6'), 6.42 (2H, s,
CH2CO), 4.81 (2H, s, CH2OH), 2.51, (1H, s, CH2OH), 2.49 (3H, s, CH3), 2,23 (3H, s, CH3). 13C-NMR:
δ 190.06 (C, C=O), 152.49 (C, C-3), 145.50 (C, C-2), 145.31 (C, C-6), 137.24 (C, C-4), 135.19 (C,
C-4'), 129.34 (C-2', C-6'), 128.59 (C, C-1'), 128.10 (C-3', C-5'), 127.80 (C, C-5), 64.42 (CH2CO),